385831-39-0

Basic information

• Product Name: ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate
• Synonyms: ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate
• CAS NO: 385831-39-0
• Molecular Weight: 309.162
• Mol File: 385831-39-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate(385831-39-0)
• EPA Substance Registry System: ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate(385831-39-0)

Safety Data

• Hazardous Substances Data: 385831-39-0(Hazardous Substances Data)

Upstream product

• 589-21-9 (4-bromophenyl)hydrazine 
• 82874-96-2 2-methoxyimino-4-oxo-pentaneperoxoic acid ethyl ester 
• 615-79-2 ethyl 2,4-diketopentanoate 
• 622-88-8 4-bromophenylhydrazine hydrochloride 

Downstream Products

• 1448684-69-2 2-(2-(5-fluorouracil-1-yl)acetamido)ethyl 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate 
• 618101-88-5 1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylic acid 

Relevant articles and documents

Hydroxamic Acid-Based Histone Deacetylase (HDAC) inhibitors bearing a pyrazole scaffold and a cinnamoyl linker

Genetic abnormalities have been conventionally considered as hallmarks of cancer. However, recent studies have demonstrated that epigenetic mechanisms are also implicated in the insurgence and development of cancer. Patterns of the epigenetic component in

PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS

The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: (I), where R1, R2, R3, R3', R4, R5, X1, X2, X3, X4, and n are described herein.